- Investing Ideas
- /
- Commercial Services Healthcare Sector
Commercial Services Healthcare Sector
Results
2304
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2304 companies
Sagimet Biosciences
Market Cap: US$111.1m
A clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States.
SGMT
US$3.45
7D
7.1%
1Y
-28.4%
Neumora Therapeutics
Market Cap: US$109.9m
A clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.
NMRA
US$0.68
7D
-3.1%
1Y
-92.6%
HLS Therapeutics
Market Cap: CA$148.0m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$4.68
7D
-2.5%
1Y
20.6%
Atossa Therapeutics
Market Cap: US$107.4m
Operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States.
ATOS
US$0.83
7D
-14.3%
1Y
-43.0%
ACC Aviation Holdings
Market Cap: US$106.2m
Focuses on developing canna powder products.
CAVG
US$0.42
7D
-6.7%
1Y
-27.3%
Vaxart
Market Cap: US$105.7m
A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States.
VXRT
US$0.46
7D
-8.2%
1Y
-46.5%
Achieve Life Sciences
Market Cap: US$105.4m
A clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction.
ACHV
US$3.04
7D
-1.3%
1Y
-43.8%
Entasis Therapeutics Holdings
Market Cap: US$104.8m
Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant pathogens in the United States.
ETTX
US$2.19
7D
0%
1Y
-14.8%
Agenus
Market Cap: US$104.7m
A clinical-stage biotechnology company, discovers and develops therapies to activate the body's immune system against cancer and infections in the United States and internationally.
AGEN
US$3.82
7D
9.8%
1Y
-72.0%
Orchestra BioMed Holdings
Market Cap: US$104.2m
Operates as a biomedical company.
OBIO
US$2.72
7D
-6.2%
1Y
-48.7%
Assembly Biosciences
Market Cap: US$103.3m
A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.
ASMB
US$13.52
7D
0.7%
1Y
-10.3%
Agape ATP
Market Cap: US$103.0m
An investment holding company, supplies health and wellness products and health solution advisory services in Malaysia.
ATPC
US$2.06
7D
0.5%
1Y
-63.0%
Xtant Medical Holdings
Market Cap: US$102.7m
Provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.
XTNT
US$0.74
7D
11.2%
1Y
-1.9%
Milestone Pharmaceuticals
Market Cap: US$102.2m
A biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.
MIST
US$1.54
7D
26.2%
1Y
-9.9%
Cassava Sciences
Market Cap: US$101.9m
A clinical stage biotechnology company, develops drugs for neurodegenerative diseases.
SAVA
US$2.11
7D
1.0%
1Y
-90.3%
iCAD
Market Cap: US$101.8m
Provides AI-powered cancer detection solutions in the United States.
ICAD
US$3.73
7D
-6.5%
1Y
136.1%
Kewaunee Scientific
Market Cap: US$101.6m
Designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products.
KEQU
US$35.60
7D
-4.6%
1Y
-13.0%
Cardiff Lexington
Market Cap: US$101.1m
Operates in the health care industry in the United States.
CDIX
US$6.50
7D
0%
1Y
-7.1%
MDxHealth
Market Cap: US$101.0m
A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.
MDXH
US$2.04
7D
-2.4%
1Y
-25.3%
Aroa Biosurgery
Market Cap: AU$155.2m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.45
7D
2.3%
1Y
-8.2%
Happy Belly Food Group
Market Cap: CA$135.9m
Provides food products in Canada.
HBFG
CA$1.05
7D
-0.9%
1Y
112.1%
Coya Therapeutics
Market Cap: US$98.7m
A clinical-stage biotechnology company, develops proprietary therapies to enhance the function of regulatory T cells (Tregs).
COYA
US$5.90
7D
-0.5%
1Y
-25.4%
Kyverna Therapeutics
Market Cap: US$98.1m
Kyverna Therapeutics, Inc., clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases.
KYTX
US$2.27
7D
-2.2%
1Y
-82.5%
BioSyent
Market Cap: CA$134.5m
Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
RX
CA$11.95
7D
1.7%
1Y
30.6%
C4 Therapeutics
Market Cap: US$98.0m
A clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins.
CCCC
US$1.38
7D
0%
1Y
-74.8%
Microbot Medical
Market Cap: US$96.5m
A clinical-stage medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space in Israel and the United States.
MBOT
US$2.66
7D
-0.7%
1Y
160.8%
OncoCyte
Market Cap: US$96.4m
Operates as a precision diagnostics company in the United States and internationally.
OCX
US$3.37
7D
20.8%
1Y
19.1%
Cuprina Holdings (Cayman)
Market Cap: US$96.3m
A biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.
CUPR
US$4.49
7D
0.2%
1Y
n/a
Genelux
Market Cap: US$96.2m
A clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.
GNLX
US$2.58
7D
4.0%
1Y
-1.5%
TurnKey Capital
Market Cap: US$96.1m
HealthSpan Medical Systems, Inc. develops marijuana based intravenous therapy (IV) infusion blends for healthcare practitioners.
TKCI
US$0.23
7D
-71.6%
1Y
n/a
Grown Rogue International
Market Cap: CA$131.6m
A craft cannabis company, focuses on premium flower and flower-derived products.
GRIN
CA$0.53
7D
-1.9%
1Y
-49.0%
Satellos Bioscience
Market Cap: CA$131.6m
A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.
MSCL
CA$0.76
7D
20.6%
1Y
58.3%
MacroGenics
Market Cap: US$95.3m
A clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States.
MGNX
US$1.51
7D
-4.4%
1Y
-66.8%
EMVision Medical Devices
Market Cap: AU$146.2m
Engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia.
EMV
AU$1.71
7D
-3.4%
1Y
-10.5%
Caribou Biosciences
Market Cap: US$94.9m
A clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally.
CRBU
US$1.02
7D
8.7%
1Y
-65.7%
Lexeo Therapeutics
Market Cap: US$93.6m
A clinical stage genetic medicine company, focuses on hereditary and acquired diseases with high unmet need in the United States.
LXEO
US$2.82
7D
-13.0%
1Y
-81.8%